Cravatex Ltd Q2 Consolidated Profit at Rs 4.62 Crore

Consolidated revenue stood at Rs 53.46 crore for the quarter ended September 30, 2026.
Net profit for the consolidated entity reached Rs 4.62 crore with an EPS of 17.88.

Reader Takeaway: Robust consolidated profit driven by international subsidiaries; standalone operations remain a minor contributor to overall financials.

What just happened

Cravatex Ltd released its unaudited financial results for the second quarter and the half-year ended September 30, 2026. The board of directors approved these results on November 3, 2026. The filing highlights a significant disparity between standalone and consolidated figures, underscoring the importance of its international holdings.

Why this matters

For investors, these figures clarify the company's reliance on its UK and European subsidiaries. While the standalone business generated a modest revenue of Rs 1.47 crore, the consolidated revenue of Rs 53.46 crore confirms that the bulk of business activity occurs through BB (UK) Limited and BB Euro GmbH. The statutory auditors issued an unmodified report, providing comfort regarding the reliability of the reported numbers.

Financial Snapshot

• Consolidated Revenue: Rs 53.46 crore for Q2; Rs 85.69 crore for the half-year.
• Consolidated Net Profit: Rs 4.62 crore for Q2; Rs 5.06 crore for the half-year.
• Standalone Revenue: Rs 1.47 crore for Q2; Rs 2.91 crore for the half-year.
• Standalone Net Profit: Rs 0.45 crore for Q2; Rs 0.86 crore for the half-year.

What to track next

Investors should monitor the company’s ability to sustain profitability across its international subsidiaries and watch for any strategic updates regarding its single-segment business model.